سعر ايموكس 250مجم فيال 2025

Amoxicillin product (E-mox 250mg vial) manufactured by EIPICO.

• Treatment of infections due to susceptible strains of designated microorganisms (e.g., ear/nose/throat, genitourinary tract, skin and skin structure, lower respiratory tract), as labeled for amoxicillin products.Population: Adults and pediatric patients as labeledDailyMed (U.S. NLM)

• Most frequently reported adverse reactions for oral amoxicillin: diarrhea, rash, vomiting, nausea. Serious reactions include anaphylaxis, severe cutaneous adverse reactions, and antibiotic-associated colitis.General active-ingredient information · DailyMed (U.S. NLM)

• History of serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or to other beta-lactam antibiotics (penicillins or cephalosporins).General active-ingredient information · DailyMed (U.S. NLM)

• Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy; Clostridium difficile-associated diarrhea has been reported with nearly all antibacterial agents including amoxicillin.General active-ingredient information · DailyMed (U.S. NLM)

• Available data from published studies have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes with amoxicillin; untreated infection during pregnancy may pose maternal/fetal risk.General active-ingredient information · DailyMed (U.S. NLM)
• Amoxicillin is present in human milk; adverse reactions in breastfed infants (e.g., diarrhea, rash, sensitization) possible; monitor the infant.General active-ingredient information · DailyMed (U.S. NLM)

• Amoxicillin: Bactericidal beta-lactam that inhibits bacterial cell-wall biosynthesis during active multiplication; inactivated by beta-lactamases (US label, section 12.4).